English
Türkçe
Laryngeal cancer is a type of cancer that develops in the structure called the larynx, commonly known as the voice box. It typically begins in the region of the vocal cords. Early symptoms include hoarseness, while advanced stages may present difficulty breathing, swallowing, and swelling in the neck. Risk factors include smoking, excessive alcohol consumption, and chronic reflux.
Symptoms of laryngeal cancer often include hoarseness, throat pain, difficulty breathing, swallowing difficulties, neck swelling or pain, ear pain, chronic cough with bloody phlegm, excessive fatigue, and weight loss. These symptoms usually become more pronounced in advanced stages and can occur together. If you experience any of these symptoms persistently, it's important to consult a healthcare professional for examination. Early diagnosis plays a crucial role in effective cancer treatment.
Several key factors contribute to the development of laryngeal cancer. The most common risk factor is the use of tobacco products, which irritates the laryngeal mucosa and predisposes to cancer cell formation. Additionally, excessive alcohol consumption increases the risk, especially when combined with smoking. Chronic reflux disease, where stomach acid regularly backs up into the esophagus, can also irritate the laryngeal mucosa and contribute to cancer development. Human papillomavirus (HPV) infection may play a role in some cases of laryngeal cancer. Genetic predisposition, specific environmental exposures (such as industrial chemicals or heavy metals), and age are also factors that can influence the risk of laryngeal cancer. The combination of these factors can increase cancer risk, but healthy lifestyle choices and regular health check-ups can help mitigate these risks or facilitate early detection.
Treatment options for laryngeal cancer include surgical intervention (removal of cancerous tissue), radiation therapy (using high-energy rays to destroy cancer cells), chemotherapy (using drugs to control or eliminate cancer cells), targeted therapies (medications targeting specific genetic or biological characteristics of the cancer), and immunotherapy (treatments that enhance the immune system's ability to recognize and eliminate cancer cells). Treatment plans are customized for each patient and typically managed by a multidisciplinary team.
